Category Archives: Momentum Trading

Eat some Mardi Gras “cake” today!

Good Morning, Trader!

Your batteries should be charged and fresh to take on today’s red hot alert.

It’s a stock that has the weight of headlines and hoopla behind it: an easy-to-explain business model in arguably the hottest sector of the year.

Management is keeping the market up to date on every little milestone, giving analysts plenty to ponder and traders all the catalysts you could ask for.

The last “little” milestone hit just last week, and it’s already created a huge impact in the company’s fundamental situation.

This Trader has Found a Trick for Beating the Market

Traders are Getting Rich Following SuperNova Stocks

Good Afternoon Trader!

With Monday being a market holiday, I wanted to take advantage of this time to remind you of a phenomenal opportunity that more than a thousand traders have already discovered to beat this market.

If you remember a short while ago, I tipped you off to one of the most profitable newsletters that traders just like yourself can get their hands on. Since that time the Nova newsletter has soared up the ranks and is currently ranked #1 out of 664 MEMBER reviewed newsletters according to an independently reviewed site — not to mention #1 in overall profit year to date according to another independent tracking system.

Senorita Takes A Look at Zoom Technologies, Inc. (Nasdaq: ZOOM). Tech Updates For BPAX And CBRX!

TGIF mi amors!

Today your Senorita is taking a look at a stock that is in such a sizzling hot sector that I give a 5 jalapeno salute to this spicy enchilada! I am talking about Zoom technologies, inc. (Nasdaq: ZOOM) a company that has subsidiaries which manufacture and distribute the latest in mobile hardware technology, and is also a major distributor for T-Mobile USA.

With offices worlwide, this aint no stinky pinky that’s for sure. With revenue projections upwards of $ 400 million this year, which would be a $ 100 million INCREASE over last year’s $ 300 million, this is one you want to put onto your watchlists immediately! This puppy trades like a low floater, and it has shown quite a few times in the past to move over $ 100% in a matter of days with a little bit of volume and interest.

For all things ZOOM check out their very informative website! http://www.zoom.com/

Support for ZOOM comes in at $ 1.30 with a lower support level of $ 1.20, resistances lies ahead at $ 1.40, $ 1.50, and then it looks like it’s bluesky territory after $ 1.70.

BCDH is giving the Roach plenty “synergy”

Good morning, Roachland!

Black Castle Developments Holding, Inc. (BCDH) is evolving into a real pint-sized conglomerate…and the “synergy” is already driving traders into a frenzy!

Take a look at those volume bars. Turnover is up 30 to 1 so far this month as BCDH makes good on its ambitions:

You’ll note that BCDH price action hasn’t exactly gone up 3,000% as yet.

Maybe this is one of those cases where “price FOLLOWS volume,” I don’t know.

Calling all amigos to a favorite in “motion”

Good Evening!

Listen up, because it’s going to get hot and heavy around here in the next few days.

Tomorrow’s alert is a niche player in some extremely high-growth markets, with some of the world’s most prestigious clients lined up for its products.
Under the right circumstances, the stock generated anywhere from 30% to over 100% a day for traders in the know.

But those “circumstances” just weren’t happening, leaving the price action in limbo…until yesterday.

Just 24 hours ago, lightning hit this stock and made it start paying out again.

It’s FDA Madness! BioSante Pharmaceuticals (Nasdaq:BPAX) And Columbia Laboratories (Nasdaq: CBRX)!

Good morning Roachland and Happy Valentine’s day!

I’m featuring 2 stocks today that have immediate FDA catalysts. Let’s kick this off with BioSante Pharmaceuticals (Nasdaq: BPAX) since today is the day that the FDA will show Bio-T Gel the love, or give them a, “Dear John” letter. In other words yay or nay to Bio-T Gel a transdermal testoserone treatment for male hypogonadism which is a $ 1.2 BILLION market in the U.S alone.

Male hypogonadism effects nearly 5 million men in the U.S. and can cause depression, hairloss, lowered sperm count, muscle loss and all sorts of problems that can even lead to infertility in the more severe cases.

So good luck to everyone that is holding shares of BioSante today! I am still in it to win it.

BioSante’s CEO Stephen M. Simes will be holding a conference and corporate update at 10:30am EST and the live feed can be found here: http://www.veracast.com/webcasts/bio/ceoinvestor2012/76206341.cfm

QUMI Has Gone From Sleeper To SWINGER!

Happy Monday, Roachland!

Quamtel, Inc. (QUMI) built a nice little high-tech business selling wireless modems and data plans for laptop users on the go…nerds love it.

Traders, on the other hand, are more impressed at how QUMI’s efforts to kick up its business have pushed its chart into overdrive!

Check it out:

Those recent QUMI volume bars are NINE TIMES as tall as they were six short weeks ago, friend.

SNET is my latest dot-com marvel

TGIF, my Roaches!

Traders in the know have given up trying to keep SourcingLink.net, Inc. (SNET) and its “car sharing” business a secret now that it’s turning heads in Hollywood. (Read more)

About 45,000 of the beautiful peopleand millions watching online…saw SNET’s limos and other luxury cars ferry the stars from party to party at this year’s Sundance Film Festival! (Read more)

The stars love anything that lets them look both fabulous and environmental, so it’s no wonder SNET’s naked push to court celebrities has its shares all revved up.

SNET: a green promise, a dot-com name and action galore!

Nibble your way through THIS, friend!

Good Evening, Trader!

Tomorrow’s alert didn’t take much “deep digging” at all to get at why its recent price action has lit up with 20% to 80% candlesticks.

This little upstart is taking on an entire industry. Its closest competitor weighs in at $ 600 million in market capitalization, and from there it’s a list of global giants.

They see this as an opportunity to snatch plenty of revenue from the big and the slow.

And while this company is currently trading well below 5 cents a share, traders evidently see the upside here too.